For example, an in vitro study demonstrated that METTL3 can activate the Notch pathway and facilitate glioma development by regulating the pathway targets NOTCH3, delta-like protein 3(DLL3), and HES1 [52]. This evidence concerns the gene METTL3 and central nervous system cancer.